Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

COG, Apeiron Join for Neuroblastoma Study

September 29, 2011 12:35 pm | News | Comments

Children´s Oncology Group (COG) and Apeiron Biologics AG will jointly investigate Apeiron´s APN301 in a clinical Phase 2 study in pediatric neuroblastoma patients.


Cat Cancer Risk Factors May Help Humans

September 29, 2011 12:30 pm | News | Comments

A large-scale study on cat intestinal cancer has provided insight into a common pet disease and its causes, a finding that could ultimately benefit humans.


Lodotra Gains New Drug Application Submission

September 29, 2011 12:23 pm | News | Comments

SkyePharma PLC announced that its licensee, Horizon Pharma, Inc. submitted a New Drug Application to the United States Food and Drug Administration for Lodotra for the treatment of active rheumatoid arthritis.


From a Healthy Cell to a Tumor

September 29, 2011 12:17 pm | News | Comments

Brain tumor specimens taken from neurosurgery cases at the University of California, San Francisco (UCSF) Medical Center have given scientists a new window on the transformation that occurs as healthy brain cells begin to form tumors.


Web-Based Document Manager

September 29, 2011 12:06 pm | Product Releases | Comments

BBK Worldwide’s DocManager v2 facilitates optimal workflow within a closed and secure web-based environment and ensures that documents are organized for various levels of review to avoid common pitfalls that delay project implementations.


Radiography Film

September 29, 2011 8:11 am | Product Releases | Comments

GE Healthcare Life Sciences has extended its range of Amersham Hyperfilm products with Amersham Hyperfilm Blue, a blue sensitive film which enables rapid, qualitative results for the detection of chemiluminescent signals in different blotting assays.


Automated Cell Culturing

September 29, 2011 8:07 am | Product Releases | Comments

The Automation Partnership's CompacT SelecT system for automated culturing of cell lines in T-flasks, is now available with an integrated Beckman Coulter Vi-CELL XR Cell Viability Analyser.


Millipore Launches Recycling Program

September 29, 2011 7:54 am | News | Comments

EMD Millipore has launched ech2o, a collection and recycling program for EMD Millipore laboratory water purification consumables. The program allows users to return exhausted cartridges for dismantling.


Pharma's Loss is Supermarket's Gain

September 29, 2011 7:47 am | News | Comments

Moody's Investors Service said that supermarkets with big pharmacy sections will get a boost to their profits in 2012 as low-cost versions of some of the world's best-selling pharmaceuticals reach the market.


OTO-104 Reduces Vertigo in New Trial

September 29, 2011 7:42 am | News | Comments

Otonomy, Inc. researchers presented positive new data from a Phase 1b study of the company’s lead product candidate, OTO-104, in patients with Ménière’s disease.


Pfizer Warning About Counterfeit Meds

September 29, 2011 7:39 am | by Linda A. Johnson | News | Comments

Pfizer Inc. and a pharmacy standards group are teaming to warn U.S. consumers about the risks of counterfeit prescription medicines, which endanger the public and take money from both pharmacies and legitimate drugmakers.


Abbott Spends $500K Lobbying Government

September 29, 2011 7:37 am | News | Comments

Drug and medical device maker Abbott Laboratories spent a half-million dollars in the second quarter to lobby the federal government on policies affecting its various products, which range from biotech drugs to infant formulas.


Soviet-Era Pill Helps Smokers Quit

September 29, 2011 7:34 am | by Maria Cheng | News | Comments

A pill developed in Bulgaria during the Soviet era shows promise for helping millions of smokers cheaply and safely kick the habit, the first big study of it shows.


Merck Sells Its Half of Joint Venture

September 29, 2011 7:30 am | News | Comments

Drugmaker Merck & Co. has sold its interest in a 22-year-old joint venture that makes and sells over-the-counter drugs to Johnson & Johnson for $175 million.


FDA Warns About Blood Clots From Drospirenone

September 28, 2011 12:26 pm | News | Comments

While the U.S. Food and Drug Administration has not reached a conclusion on the risk for blood clots in women using drospirenone-containing birth control pills, the agency released an updated safety announcement regarding its concerns about the potential increased risk.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.